The ATTAIN-MAINTAIN trial found that people who switched from injectable Mounjaro or Wegovy to oral orforglipron (Foundayo) were able to maintain most of their weight loss over 52 weeks

Experimental Research Applications In scientific literature, Retatrutide has been investigated in a variety of experimental settings, including: Triple receptor agonism research GIP, GLP-1, and glucagon pathway co-activation Obesity and body weight regulation mechanism studies Energy expenditure and thermogenesis pathway research (glucagon receptor) Visceral and hepatic fat reduction and MASLD/hepatic steatosis models Type 2 diabetes, insulin resistance, and glycemic control research Lipid buffering and GIP receptor signaling studies Satiety and appetite regulation pathway investigations Albumin binding, acylation chemistry, and extended half-life peptide research Comparative mono/dual/triple agonist mechanistic studies These studies are conducted exclusively within laboratory and preclinical environments and are intended for mechanistic and observational research purposes
It has high bioavailability compared to many other dietary polyphenols
Gomarasca P et al
Avoid freezing the reconstituted solution, since freezethaw can denature the peptide
9 E 68th Street, 1C, New York, NY 10065